Charlie Munger on When NOT to Sell a Stock
Charlie Munger argues that selling great businesses prematurely is the most destructive financial decision investors make, far more damaging than buying the wrong stock. He distinguishes between the rare legitimate reasons to sell—permanent competitive deterioration, management dishonesty, or a dramatically better opportunity—versus the emotional and psychological reasons most investors actually sell. The core thesis is that truly great compounding businesses are extraordinarily rare and should be held with patience rather than traded away for short-term comfort.
Summary
Munger opens by framing the central paradox: the most wealth-destroying decision investors make is not buying the wrong thing, but selling the right thing. He describes watching intelligent, diligent investors find great businesses, only to sell them after a price increase and then watch those same businesses compound at 20% annually for decades while the sellers sat in Treasury bills.
He then dissects the 'price target' approach to selling, calling it a catastrophic intellectual error rooted in confusing a stock's price with a business's value. The stock price, he argues, is an emotionally-driven number that bounces around, while the business itself is a living, compounding organism. Great investors watch the business; most investors watch the price.
Munger acknowledges that earlier in his and Buffett's careers, when capital pools were small, a 'cigarette butt' strategy of buying cheap mediocre businesses and selling when fairly priced made sense. But he explains this approach breaks down at scale and, more importantly, causes investors to exit compounding machines—the rarest and most valuable finds in investing.
He outlines three legitimate reasons to sell: (1) permanent, structural deterioration of the business's competitive position—not a bad quarter, but an irreversible loss of the underlying advantage; (2) a serious breach of management trust, specifically dishonesty or consistently destructive capital allocation; and (3) finding something dramatically—not marginally—better, where the gap clearly covers taxes, friction, and the uncertainty of leaving a known great business.
Munger then enumerates the wrong reasons investors actually sell: the stock has gone up a lot (confusing price movement with a change in business quality); fear about macroeconomic conditions (which forces two correct decisions instead of one—timing the exit and the re-entry); and deference to confident analysts whose DCF models create false precision, particularly by underestimating the value of outer compounding years.
He introduces the concept of 'activity bias'—the deeply human belief that doing something is always better than doing nothing—as the real psychological enemy of long-term investors. Selling feels decisive and provides a sense of control, but the compounding math over 30-40 years is ruthless in punishing unnecessary exits from great businesses.
Munger offers a practical five-question framework for evaluating a potential sale: Has anything changed about the business itself? Can I identify something dramatically better? Am I selling for a business reason or a psychological one? What are the full costs of selling, including foregone compounding? And finally, would I buy this business today at today's price—because if yes, there is no rational reason to sell what you already own.
He closes with a philosophical point about investor-partner relationships, arguing that transparency about long-term orientation attracts the right kind of partners who won't pressure managers into short-term, wealth-destroying decisions. The ultimate goal, he concludes, is not to be clever about when to sell, but to own great businesses for long periods and have the patience to let compounding do its work.
Key Insights
- Munger argues that setting a price target is a 'catastrophic intellectual error' because it conflates the price of a stock—an emotionally-driven number set by millions of people on any given Tuesday—with the value of a business, which is a living compounding organism with competitive advantages, management quality, and earnings power.
- Munger contends that the true cost of selling a great business is not just the tax bill but the future compounding foregone, the friction of redeployment, and the high probability that the alternative investment is inferior—making the full cost of selling 'shocking' when honestly calculated.
- Munger claims that selling out of macroeconomic fear is particularly destructive because it converts one decision into two: the investor must be correct both about the market declining and about the precise moment to re-enter, and the historical evidence shows most investors miss the recovery entirely while waiting for a second drop.
- Munger argues that activity bias—the belief that doing something is always better than doing nothing—is the 'real enemy' of long-term investing, because selling feels decisive and reduces short-term anxiety but the compounding math over 30-40 years makes every unnecessary exit from a great business catastrophically expensive.
- Munger presents a litmus test for holding versus selling: if you would be willing to buy the business at today's price knowing what you know now, then selling is irrational because the only mechanical difference between buying and holding is transaction costs and taxes—both of which favor holding.
Topics
Full transcript available for MurmurCast members
Sign Up to Access